Skip Navigation

Cardiovascular Research 1997 35(3):522-528; doi:10.1016/S0008-6363(97)00151-X
© 1997 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Tanner, F. C
Right arrow Articles by Nabel, E. G
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanner, F. C
Right arrow Articles by Nabel, E. G
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1997, European Society of Cardiology

Transfection of human endothelial cells

Felix C Tannera, Dianne P Carra, Gary J Nabela,c,d and Elizabeth G Nabela,b,*

aDepartment of Internal Medicine, University of Michigan, 1150 W. Medical Center Drive, 7220 MSRB III Ann Arbor, MI 48109-0644, USA
bDepartment of Physiology, University of Michigan, Ann Arbor, MI 48109-0644, USA
cDepartment of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109-0644, USA
dHoward Hughes Medical Institute, University of Michigan, Ann Arbor, MI 48109-0644, USA

* Corresponding author. Tel.: +1 313 7635103; Fax: +1 313 7634851.

Objective: The introduction of recombinant genes into endothelial cells provides a method to study specific gene products and their effect on cell function. In addition, endothelial cells can be used for implantation into vessels or prosthetic vascular grafts. Because transfection efficiencies in human endothelial cells have been low, it is important to develop improved gene transfer techniques. Therefore, several transfection methods were optimized and transfection efficiencies were determined. Methods: Transfection by particle-mediated gene transfer (biolistics) or by cationic liposomes were optimized and compared to calcium phosphate and DEAE-dextran. Transfection efficiency was determined using either a β-galactosidase or placental alkaline phosphatase reporter gene. The effect of promoter strength was analyzed by transfecting plasmids with either the Rous sarcoma virus (RSV) promoter or cytomegalovirus (CMV) promoter regions. Results: Optimal conditions for particle-mediated gene transfer utilized gold particles of 1.6 µm diameter, a target distance of 3 cm, helium pressures of 8.96 MPa (1300 psi) and cell confluence of 75%. Transfection with different cationic liposomes demonstrated that one compound, N-(3-aminopropyl)-N,N-dimethyl-2,3-(bis-dodecyloxy)-1-propaniminium bromide/dioleoyl phosphatidylethanolamine ({gamma}AP-DLRIE/DOPE), was optimal for gene transfer when 5 µg of DNA and 10 to 20 µg of lipid was used. With both gold particles and {gamma}AP-DLRIE/DOPE, the alkaline phosphatase reporter was more efficient than β-galactosidase using comparable promoters and polyadenylation sites. CMV regulatory elements were more efficient than the RSV promoter in optimizing gene expression. Optimal gene transfer efficiency was 20.28% of cells with {gamma}AP-DLRIE/DOPE, 3.96% with biolistics, 2.09% with calcium phosphate and 0.88% with DEAE-dextran. Conclusions: Gene expression is detectable in a high percentage of human endothelial cells after liposome-mediated transfection when expression is controlled by a strong promoter. Particle-mediated transfection is less efficient under these conditions, but more effective than liposomes when expression is driven by a relatively weak promoter. Calcium phosphate and DEAE-dextran are less useful.

KEYWORDS Endothelium; Human; Transfection; Gene expression; Particle bombardment; Cationic liposomes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
IOVSHome page
J. Zhou, B. K. Deo, K. Hosoya, T. Terasaki, I. G. Obrosova, F. C. Brosius III, and A. K. Kumagai
Increased JNK Phosphorylation and Oxidative Stress in Response to Increased Glucose Flux through Increased GLUT1 Expression in Rat Retinal Endothelial Cells
Invest. Ophthalmol. Vis. Sci., September 1, 2005; 46(9): 3403 - 3410.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. C. Tanner, T. Largiader, H. Greutert, Z. Yang, and T. F. Luscher
Nitric oxide synthase gene transfer inhibits biological features of bypass graft disease in the human saphenous vein
J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 20 - 26.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. P. Tabruyn, C. M. Sorlet, F. Rentier-Delrue, V. Bours, R. I. Weiner, J. A. Martial, and I. Struman
The Antiangiogenic Factor 16K Human Prolactin Induces Caspase-Dependent Apoptosis by a Mechanism that Requires Activation of Nuclear Factor-{kappa}B
Mol. Endocrinol., September 1, 2003; 17(9): 1815 - 1823.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. Guetta, E. M Scarpati, and P. E DiCorleto
Effect of cytomegalovirus immediate early gene products on endothelial cell gene activity
Cardiovasc Res, June 1, 2001; 50(3): 538 - 546.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. T. KOVALA, K. A. HARVEY, P. McGLYNN, G. BOGUSLAWSKI, J. G. N. GARCIA, and D. ENGLISH
High-efficiency transient transfection of endothelial cells for functional analysis
FASEB J, December 1, 2000; 14(15): 2486 - 2494.
[Abstract] [Full Text]


Home page
CirculationHome page
F. C. Tanner, P. Meier, H. Greutert, C. Champion, E. G. Nabel, and T. F. Luscher
Nitric Oxide Modulates Expression of Cell Cycle Regulatory Proteins : A Cytostatic Strategy for Inhibition of Human Vascular Smooth Muscle Cell Proliferation
Circulation, April 25, 2000; 101(16): 1982 - 1989.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Zeng, F. H. Nystrom, L. V. Ravichandran, L.-N. Cong, M. Kirby, H. Mostowski, and M. J. Quon
Roles for Insulin Receptor, PI3-Kinase, and Akt in Insulin-Signaling Pathways Related to Production of Nitric Oxide in Human Vascular Endothelial Cells
Circulation, April 4, 2000; 101(13): 1539 - 1545.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
N. Wang, L. Verna, S. Hardy, Y. Zhu, K.-S. Ma, M. J. Birrer, and M. B. Stemerman
c-Jun Triggers Apoptosis in Human Vascular Endothelial Cells
Circ. Res., September 3, 1999; 85(5): 387 - 393.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
N. Wang, L. Verna, S. Hardy, J. Forsayeth, Y. Zhu, and M. B. Stemerman
Adenovirus-Mediated Overexpression of c-Jun and c-Fos Induces Intercellular Adhesion Molecule-1 and Monocyte Chemoattractant Protein-1 in Human Endothelial Cells
Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2078 - 2084.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.